Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma

被引：7
|
作者：
Coiffier, B [1 ]
机构：
[1] Ctr Hosp Lyon Sud, Hematol Serv, Lyon, France
来源：
TUMORI | 2002年 / 88卷 / 01期
关键词：
D O I：
10.1177/030089160208800108
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S26 / S28
页数：3
相关论文
共 50 条
  • [21] Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma
    Vose, JM
    Link, BK
    Grossbard, ML
    Czuczman, M
    Grillo-Lopez, A
    Fisher, RI
    LEUKEMIA & LYMPHOMA, 2005, 46 (11) : 1569 - 1573
  • [22] Treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma with a combination of a taxane, cyclophosphamide and rituximab.
    Krämer, A
    Zoz, M
    Krasniqi, F
    Görner, M
    Leo, E
    Ho, AD
    BLOOD, 2001, 98 (11) : 135A - 135A
  • [23] Intensified chop (CHOP14) plus rituximab in the treatment of elderly patients with aggressive and high risk non Hodgkin's lymphoma (NHL).
    Rigacci, L
    Nassi, L
    Alterini, R
    Carrai, V
    Bernardi, F
    Martini, V
    Bernardeschi, P
    Longo, G
    Bosi, A
    Morfini, M
    BLOOD, 2004, 104 (11) : 228B - 228B
  • [24] Long term follow up of the patients with non-Hodgkin's Lymphoma treated with Rituximab in combination with CHOP regimen.
    Li, JM
    BLOOD, 2005, 106 (11) : 274B - 274B
  • [25] Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma
    Fridrik, Michael A.
    Hausmaninger, Hubert
    Lang, Alois
    Drach, Johannes
    Krieger, Otto
    Geissler, Dietmar
    Michlmayr, Gerhard
    Ulsperger, Ernst
    Chott, Andreas
    Oberaigner, Wilhelm
    Greil, Richard
    ANNALS OF HEMATOLOGY, 2010, 89 (03) : 273 - 282
  • [26] Dose-dense therapy improves survival in aggressive non-Hodgkin’s lymphoma
    Michael A. Fridrik
    Hubert Hausmaninger
    Alois Lang
    Johannes Drach
    Otto Krieger
    Dietmar Geissler
    Gerhard Michlmayr
    Ernst Ulsperger
    Andreas Chott
    Wilhelm Oberaigner
    Richard Greil
    Annals of Hematology, 2010, 89 : 273 - 282
  • [27] Quality of life (QOL) in elderly patients with aggressive non-Hodgkin's lymphoma. (NHL) treated with CHOP.
    Doorduyn, JK
    Buijt, I
    Uyl-de Groot, CA
    van der Holt, B
    Sonneveld, P
    BLOOD, 2001, 98 (11) : 430A - 430A
  • [28] Role of anemia in survival of elderly aggressive non-Hodgkin's lymphoma patients following chemotherapy.
    Zinzani, PL
    Tani, M
    Molinari, AL
    Visani, G
    Gentilini, P
    Guardigni, L
    Stefoni, V
    Alinari, L
    Marchi, E
    Gabriele, A
    Musuraca, G
    Fina, MP
    Baccarani, M
    BLOOD, 2004, 104 (11) : 906A - 906A
  • [29] Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy
    Doorduijn, J
    Buijt, I
    Holt, B
    Steijaert, M
    Uyl-de Groot, C
    Sonneveld, P
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (02) : 116 - 123
  • [30] Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma
    Kilickap, Saadettin
    Yavuz, Bunyamin
    Aksoy, Sercan
    Sahiner, Levent
    Harputluoglu, Hakan
    Dincer, Murat
    Erman, Mustafa
    Aytemir, Kudret
    Tokgozoglu, Lale
    Barista, Ibrahim
    ANNALS OF ONCOLOGY, 2006, 17 : 202 - 202
12345